Trial is under way for SynapDx's early autism test

05/10/2013 | American City Business Journals

SynapDx is conducting a clinical trial to test its blood-based assay in diagnosing autism in children 18 months or older. The trial, launched last month, involves 660 children at 20 clinical sites. The average age at which autism is detected is 4.5 years, and earlier detection would allow earlier treatment.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health